Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium

Gastroenterology. 2021 Mar;160(4):999-1002. doi: 10.1053/j.gastro.2020.10.030. Epub 2020 Oct 21.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19 / epidemiology*
  • Early Detection of Cancer / economics
  • Early Detection of Cancer / statistics & numerical data*
  • Health Status Disparities
  • Humans
  • National Cancer Institute (U.S.)
  • Occult Blood
  • SARS-CoV-2*
  • United States